Development of transgenic mouse models for the study of human olfactory dysfunction

American Journal of Rhinology

Volumn 19, Issue 3, 2005, Pages 229-235

  Land, Andrew P ^a,c   Zhao, Haiqing ^b   Reed, Randall R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE;

CELL FUNCTION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENE INSERTION; GENE TARGETING; IN VIVO STUDY; MEDICAL RESEARCH; MOUSE; MOUSE STRAIN; NONHUMAN; OLFACTORY DISCRIMINATION; OLFACTORY EPITHELIUM; OLFACTORY NERVE DISEASE; OLFACTORY RECEPTOR; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SMELLING DISORDER;

EID: 21644436015     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.1177/194589240501900302     Document Type: Review

References (18)

1. Bramerson A, Johansson L, Ek L, et al. Prevalence of olfactory dysfunction: The Skovde population-based study. Laryngoscope 114:733-737, 2004.
2. Blackwell D, Collins JG, and Colles R. Summary health statistics for U.S. adults: National Health Interview Survey, 1997. Vital Health Stat 10:15-16, 2002.
3. Palmiter RD, and Brinster RL. Germ-line transformation of mice. Annu Rev Genet 20:465-499, 1986.
4. Bockamp E, Maringer M, Spangenberg C, et al. Of mice and models: Improved animal models for biomedical research. Physiol Genomics 11:115-132, 2002.
5. Margolis FL. Olfactory marker protein (OMP). Scand J Immunol Suppl 9:181-199, 1982.
6. Zhu Z, Zheng T, Lee CG, et al. Tetracycline-controlled transcriptional regulation systems: Advances and application in trangenic animal modeling. Semin Cell Dev Biol 13:121-128, 2002.
7. Wang Y, Tsai SY, and O'Malley BW. An antiprogestin regulable gene switch for induction of gene expression in vivo. Adv Pharmacol 47:343-355, 2000.
8. Feil R, Brocard J, Mascrez B, et al. Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci USA. 93:10887-10890, 1996.
9. Sauer B, and Henderson N. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci USA 85:5166-5170, 1988.
10. Treloar HB, Feinstein P, Mombaerts P, and Greer CA. Specificity of glomerular targeting by olfactory sensory axons. J Neurosci 22:2469-2477, 2002.
11. Wong ST, Trinh K, Hacker B, et al. Disruption of the type III adenylyl cyclase gene leads to peripheral and behavioral anosmia in transgenic mice. Neuron 27:487-497, 2000.
12. Belluscio L, Gold GH, Nemes A, and Axel R. Mice deficient in G(olf) are anosmic. Neuron 20:69-81, 1998.
13. Baker H, Cummings DM, Munger SD, et al. Targeted deletion of a cyclic nucleotide-gated channel subunit (OCNC1): Biochemical and morphological consequences in adult mice. J Neurosci 19:9313-9321, 1999.
14. Cau E, Casarosa S, and Guillemot F. Mash1 and Ngn1 control distinct steps of determination and differentiation in the olfactory sensory neuron lineage. Development 129:1871-1880, 2002.
15. Doty RL, and Mishra A. Olfaction and its alteration by nasal obstruction, rhinitis, and rhinosinusitis. Laryngoscope 111:409-423, 2001.
16. Kern RC, Conley DB, Haines GK III, and Robinson AM. Pathology of the olfactory mucosa: Implications for the treatment of olfactory dysfunction. Laryngoscope 114:279-285, 2004.
17. Heilmann S, Huettenbrink KB, and Hummel T. Local and systemic administration of corticosteroids in the treatment of olfactory loss. Am J Rhinol 18:29-33, 2004.
18. Hua ZC, and Ding X. cDNA cloning and heterologous expression of mouse CYP2G1. Ann NY Acad Sci 864:309-312, 1998.